TH1801005150A - Pharmaceutical constituents for the improvement or prevention of chronic kidney disease - Google Patents

Pharmaceutical constituents for the improvement or prevention of chronic kidney disease

Info

Publication number
TH1801005150A
TH1801005150A TH1801005150A TH1801005150A TH1801005150A TH 1801005150 A TH1801005150 A TH 1801005150A TH 1801005150 A TH1801005150 A TH 1801005150A TH 1801005150 A TH1801005150 A TH 1801005150A TH 1801005150 A TH1801005150 A TH 1801005150A
Authority
TH
Thailand
Prior art keywords
prevention
improvement
kidney disease
chronic kidney
pharmaceutical constituents
Prior art date
Application number
TH1801005150A
Other languages
Thai (th)
Inventor
อันคิต แซม ซิงห์
เวดพราคาซ มิชรา
นีลิมา ตนกรา
Original Assignee
นางดารานีย์ วัจนะวุฒิวงศ์
นางสาวสนธยา สังขพงศ์
นางสาวสุคนธ์ทิพย์ จิตมงคลทอง
Filing date
Publication date
Application filed by นางดารานีย์ วัจนะวุฒิวงศ์, นางสาวสนธยา สังขพงศ์, นางสาวสุคนธ์ทิพย์ จิตมงคลทอง filed Critical นางดารานีย์ วัจนะวุฒิวงศ์
Publication of TH1801005150A publication Critical patent/TH1801005150A/en

Links

Claims (1)

: ข้อถือสิทธิ์ (ข้อที่หนึ่ง) ซึ่งจะปรากฏบนหน้าประกาศโฆษณา : แก้ไข 23/11/2561 หน้า 1 ของจำนวน 3 หน้า &nbแท็ก : สิทธิบัตรยา: Privilege (number one) which will appear on the advertisement page: Edit 23/11/2018 Page 1 of 3 pages & nb Tag: drug patent.
TH1801005150A 2018-08-30 Pharmaceutical constituents for the improvement or prevention of chronic kidney disease TH1801005150A (en)

Publications (1)

Publication Number Publication Date
TH1801005150A true TH1801005150A (en) 2020-02-03

Family

ID=

Similar Documents

Publication Publication Date Title
TH1801005150A (en) Pharmaceutical constituents for the improvement or prevention of chronic kidney disease
TH180895A (en) Surgical bed
TH1701002034A (en) Composition and methods of use for the treatment of metabolic disorders
TH1701003406A (en) Pharmaceutical formulation of tropomieosin-related kinase inhibitors (TRK).
TH1701005384A (en) Composition for the treatment of fibrosis And membrane-related conditions
TH2001006197A (en) compounds replaced by oxo
TH1801007603A (en) 1-Tetrahydropyranil Carbonyl-2,3-Dihydro-1H-Indole Compound for Cancer Treatment
TH191393S (en) Earring
TH191390S (en) Earring
TH1701001067A (en) Pharmaceutical components and therapeutic combinations containing substances Inhibits cholesterol-transmitted proteins and HMG CoA reductase inhibitors.
TH1601005698A (en) Powdered biological products for the prevention of plant black spot disease.
TH178555A (en) Heteroerril derivatives Or its pharmaceutical acceptable salt, method of preparation, and pharmaceutical constituents for the prevention or treatment of disease. Associated with PI3 kinase, which has the same thing as active ingredient.
TH185031S (en) chair
TH186788S (en) Hanger lock
TH182291S (en) chair
TH1601004527A (en) Muscarinic M1 receptor bicyclic acid bicyclic compound
TH1801008033A (en) The ABS structure of the straddle vehicle
TH1701004077A (en) Active substance for improving early insulin secretion capacity.
TH181502S (en) chair
TH181499S (en) chair
TH181500S (en) chair
TH1701004168A (en) Elements that can be dispersed
TH1901000739A (en) New use of N, N-bis-2-mercaptoethyl Isopthalamide
TH182678A (en) Tetrahydroquinoline derivatives, bromodomain inhibitors
TH1701002657A (en) Constituents containing naracin for the treatment of viral infections.